Serial Number | 97249797 |
Word Mark | DTX PHARMA |
Filing Date | Wednesday, February 2, 2022 |
Status | 732 - THIRD EXTENSION - GRANTED |
Status Date | Tuesday, January 14, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 23, 2023 |
Goods and Services | Pharmaceutical preparations, namely, oligonucleotide compounds; oligonucleotide compounds for the treatment of genetic diseases; oligonucleotide delivery agents in the form of intravenous infusion or injection, suspension or sterile powder for the treatment of genetic diseases; pharmaceutical preparations for the treatment of genetic diseases; therapeutic preparations using RNA to treat ocular, neuromuscular and central nervous system (CNS) diseases; fatty acid-based oligonucleotide delivery agents in the form of intravenous infusion or injection, suspension or sterile powder for the treatment of genetic diseases |
NOT AVAILABLE | "PHARMA" |
Goods and Services | Pharmaceutical research and development of oligonucleotide compounds; scientific research and product development in the field of oligonucleotide compounds and drug discovery; Pharmaceutical research and development of fatty acid-based drug delivery platforms for use in therapeutic discovery and development; Pharmaceutical research and development of fatty acid-based drug delivery platforms for use in the treatment of genetic diseases; Pharmaceutical research and development of therapeutic preparations using RNA to treat ocular, neuromuscular and central nervous system (CNS) diseases |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, April 19, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, April 19, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | DTx Pharma, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92121 |
Party Name | DTx Pharma, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92121 |
Event Date | Event Description |
Saturday, February 5, 2022 | NEW APPLICATION ENTERED |
Tuesday, February 8, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 11, 2022 | ASSIGNED TO EXAMINER |
Monday, October 24, 2022 | NON-FINAL ACTION WRITTEN |
Monday, October 24, 2022 | NON-FINAL ACTION E-MAILED |
Monday, October 24, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, April 19, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 19, 2023 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, April 19, 2023 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, April 19, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, April 19, 2023 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, May 3, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 23, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, May 23, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 18, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, December 12, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, December 12, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, January 8, 2024 | SOU TEAS EXTENSION RECEIVED |
Monday, January 8, 2024 | SOU EXTENSION 1 FILED |
Monday, January 8, 2024 | SOU EXTENSION 1 GRANTED |
Wednesday, January 10, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, July 11, 2024 | SOU TEAS EXTENSION RECEIVED |
Thursday, July 11, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, July 11, 2024 | SOU EXTENSION 2 GRANTED |
Thursday, July 11, 2024 | SOU EXTENSION 2 FILED |
Tuesday, January 14, 2025 | SOU TEAS EXTENSION RECEIVED |
Tuesday, January 14, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, January 14, 2025 | SOU EXTENSION 3 GRANTED |
Tuesday, January 14, 2025 | SOU EXTENSION 3 FILED |
Tuesday, December 12, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Tuesday, December 12, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |